President Barack Obama makes a historic visit to Hiroshima. The Taliban choose a new leader after a U.S. drone strike kills Mullah Mansour. And a far right candidate in Austria narrowly loses the presidential election. A panel of journalists joins guest host Sabri Ben-Achour for analysis of the week's top international news stories.
The Vioxx recall is just the latest of several episodes this year that have prompted criticism of the FDA and Senate hearings. A panel talks about the drug approval process, post-marketing safety surveillance, and how the agency’s work affects Americans’ health and safety.
- Dr. Jerry Avorn author of "Powerful Medicines," professor of medicine at Harvard Medical School, and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston
- Sen. Charles Grassley (R-Iowa), ranking member of the Senate Finance Committee
- Marc Kaufman reporter on the national desk of "The Washington Post"
- Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
- Dr. Sandra Kweder deputy director of the FDA's Office of New Drugs
Most Recent Shows
Donald Trump now has enough delegates to clinch the Republican nomination, according to the Associated Press. A State Department review criticizes Hillary Clinton's use of a private email server. And 11 states sue the federal government over a transgender bathroom directive. A panel of journalists joins guest host Sabri Ben-Achour for analysis of the week's top national news stories
A massive forest fire has been raging in Alberta, Canada, for nearly a month. Scientists say warmer, drier weather has increased the frequency and intensity of fires. For this month's Environmental Outlook: wildfires, climate change and threats to North America’s forests.
Congress is updating a 40-year-old federal law regulating thousands of chemicals in daily use. The bipartisan bill has support from many industry groups and public health advocates, but some in the environmental community say it doesn't go far enough. A look at regulating the safety of chemicals.